全文获取类型
收费全文 | 72481篇 |
免费 | 6975篇 |
国内免费 | 2460篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 793篇 |
妇产科学 | 2030篇 |
基础医学 | 3514篇 |
口腔科学 | 579篇 |
临床医学 | 6672篇 |
内科学 | 7617篇 |
皮肤病学 | 1141篇 |
神经病学 | 2261篇 |
特种医学 | 726篇 |
外国民族医学 | 7篇 |
外科学 | 2601篇 |
综合类 | 9024篇 |
现状与发展 | 9篇 |
一般理论 | 4篇 |
预防医学 | 4959篇 |
眼科学 | 720篇 |
药学 | 32012篇 |
47篇 | |
中国医学 | 3109篇 |
肿瘤学 | 3933篇 |
出版年
2024年 | 160篇 |
2023年 | 1189篇 |
2022年 | 1583篇 |
2021年 | 2622篇 |
2020年 | 2655篇 |
2019年 | 2661篇 |
2018年 | 2754篇 |
2017年 | 2999篇 |
2016年 | 2852篇 |
2015年 | 2905篇 |
2014年 | 4828篇 |
2013年 | 8344篇 |
2012年 | 4688篇 |
2011年 | 4932篇 |
2010年 | 3850篇 |
2009年 | 3633篇 |
2008年 | 3380篇 |
2007年 | 3344篇 |
2006年 | 3000篇 |
2005年 | 2692篇 |
2004年 | 2311篇 |
2003年 | 2023篇 |
2002年 | 1555篇 |
2001年 | 1447篇 |
2000年 | 1163篇 |
1999年 | 977篇 |
1998年 | 866篇 |
1997年 | 801篇 |
1996年 | 653篇 |
1995年 | 615篇 |
1994年 | 525篇 |
1993年 | 459篇 |
1992年 | 513篇 |
1991年 | 416篇 |
1990年 | 345篇 |
1989年 | 279篇 |
1988年 | 265篇 |
1987年 | 252篇 |
1986年 | 211篇 |
1985年 | 222篇 |
1984年 | 175篇 |
1983年 | 143篇 |
1982年 | 118篇 |
1981年 | 92篇 |
1980年 | 64篇 |
1979年 | 64篇 |
1978年 | 72篇 |
1977年 | 49篇 |
1976年 | 48篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 828 毫秒
91.
目的探讨一对一责任助产加笑气吸入对分娩镇痛的疗效。
方法将576例产妇随机分为观察组和对照组.每组288例,两组均采用一对一责任助产及其他产科处理措施,观察组同时给予笑气吸入.观察两组的产痛程度、产程时间、分娩方式、笑气对新生儿的影响、产后出血及尿潴留等。
结果观察组无痛分娩率达95.8%.而对照组则为0(P〈0.01),观察组的产程时间短于对照组(P〈0.01)。
结论笑气吸入分娩镇痛产程时间短,对母婴均无不良影响,加一对一责任助产.是一种理想的分娩方法,值得产科临床推广使用。 相似文献
92.
Hung-Yen Chin Min-Chi Chen Yu-Hung Liu Kuo-Hwa Wang 《International urogynecology journal》2006,17(6):631-635
The aim of this study was to assess the impact of delivery on the pelvic floor and whether cesarean section (C/S) can prevent pelvic floor injury. Five hundred thirty nine women were divided into three groups according to the delivery method adopted: elective C/S, emergent C/S, and vaginal delivery. A urinary incontinence questionnaire survey was conducted around 1 year postpartum. Emergent C/S may be a major risk factor for postpartum urinary incontinence and interfere with the benefit of elective C/S for preventing pelvic floor injury. Hence, not all C/S deliveries can reduce the likelihood of postpartum urinary incontinence. The key lies in whether the C/S is performed before labor. 相似文献
93.
94.
95.
AKIKO TANAKA MASAHIRO MATSUMOTO YUJIRO HAYASHI KOJI TAKEUCHI 《Journal of gastroenterology and hepatology》2006,20(1):38-45
Background and Aim: We recently reported that cyclooxygenase (COX)-2 is upregulated in the rat small intestine after administration of indomethacin, and this may be the key to non-steroidal anti-inflammatory drug (NSAID)-induced intestinal damage. The present study investigated the mechanism for COX-2 expression induced in the rat small intestine by indomethacin, in relation with ulcerogenic processes.
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE2 content was decreased by SC-560 at 3 h but recovered 12 h later, and this recovery of PGE2 was attenuated by both atropine and ampicillin, in addition to rofecoxib. The intestinal hypermotility response to indomethacin was prevented by both 16,16-dimethyl PGE2 and atropine, but not ampicillin. Yet all these agents inhibited not only the bacterial invasion but also the expression of COX-2 and iNOS activity in the intestinal mucosa following indomethacin treatment, resulting in the prevention of intestinal lesions.
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献
96.
Michael W. Anderson MD Kanika Sharma MD Colin M. Feeney MD 《Academic emergency medicine》1997,4(8):805-809
The incidence of wound botulism is increasing and the epidemiology of the disease is changing. The majority of new cases are associated with injection drug use, in particular, the use of Mexican black tar heroin. This case report and discussion of wound botulism illustrate the following important points: Dysphagia, dysphonia, diplopia, and descending paralysis, in association with injection drug use, should alert the treating physician to the possibility of wound botulism. In such patients, the onset of respiratory failure may be sudden and without clinically obvious signs of respiratory weakness. For the reported patient, maximum inspiratory force measurements were the only reliable indicator of respiratory muscle weakness. This is a measurement not routinely performed in the ED, but may prove essential for patients with suspected wound botulism. To minimize the effect of the botulinum toxin and to decrease length of hospital stay, antitoxin administration and surgical wound debridement should be performed early. 相似文献
97.
药物传递系统(DDS)Ⅳ腔道给药传递系统 总被引:2,自引:0,他引:2
腔道给药是能起全身作用、避开肝首过代谢作用、患者便于自用的非损伤性给药途径。本文着重介绍影响鼻腔、阴道给药药物吸收的生物因素和剂型因素及正在开发的腔道给药传递系统。 相似文献
98.
P. A. Milligan P. E. McGill C. W. Howden A. W. Kelman B. Whiting 《European journal of clinical pharmacology》1993,45(6):507-512
Summary A randomised crossover study was performed in subjects with rheumatoid arthritis (or other arthropathies) to investigate if any alteration in the steady pharmacokinetics of the NSAID piroxicam (a drug which is extensively metabolised via cytochrome P450) or its major metabolites occurred as a result of coadministering either cimetidine or nizatidine.Twelve females and 2 males with mean age, weight, and albumin concentrations of 58 years, 61 kg, and 40 g·L–1 respectively, completed the study. Comparisons were made between the following parameters: plasma piroxicam AUCs [AUC0-24(P)], plasma 5-hydroxypiroxicam AUCs [AUC0-24(5-OHP)], the ratio of these i.e. AUC0-24(5-OHP):AUC0-24(p), the % piroxicam daily dose excreted in urine as 5-hydroxypiroxicam (before and after glucuronidase incubation); and the mean of the steady state trough piroxicam, and 5-hydroxypiroxicam concentrations (obtained during each study phase in addition to the wash-out period).A statistically significant difference as a result of initiating either cimetidine or nizatidine was obtained only for the ratio AUC0-23(5-OHP):AUC0-24(P). This was indicative of a weak potential to inhibit piroxicam hydroxylation.No clinically significant alteration in the steady state pharmacokinetics of piroxicam occurred in these subjects as a result of cimetidine or nizatidine coadministration. Consequently it is unlikely that any adverse events would arise from these combinations. 相似文献
99.
With the advent of genomics, combinatorial paradigms and high-throughput screen (HTS)-based pharmacological testing, the number of compounds flowing through the discovery pipeline is likely to escalate. At the same time, with increased knowledge of the human drug-metabolizing enzymes and the availability of in vitro absorption-metabolism (AM) models, Preclinical Drug Metabolism is poised to meet the challenges of HTS. In order to be successful, however, a rational HTS strategy (vs. serendipitous HTS) has to be employed. Such a strategy is based on automation, validation and integration of in vitroAM models and database management (AVID). A generalized strategy for rational (AVID-based) HTS in Preclinical Drug Metabolism is described briefly. 相似文献
100.
Carlo Bertucci Enrico Domenici Piero Salvadori 《Journal of pharmaceutical and biomedical analysis》1990,8(8-12):843-846
The application of a circular dichroism (c.d.) detection system in HPLC using a chiral stationary phase is presented. The simultaneous measurement of the absorbance and c.d. signal allows the evaluation of the anisotropy factor (g = Δ/) and thus the determination of the enantiomeric excess (e.e.) of the eluates. When this detection system is used in preparative chiral chromatography the collection of the enantiomeric fractions can be readily optimized. 相似文献